How a new cystic fibrosis drug enters the blood
Treatments studied
This study tests a new medicine called florensocatib in healthy men to see how it is absorbed when taken alone or with a medicine that reduces stomach acid. It helps researchers understand the best way to take the drug for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man aged 18 or older.
- Your body mass index (BMI) is between 18 and 30.
- You weigh between 45 and 100 kg (about 99 to 220 pounds).
- You are a non-smoker or have smoked very little in the past.
- You are willing to use contraception during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a new tablet version of an experimental medicine (VX-581) is absorbed by the body. It may help researchers find the best way to give this medicine in the future.
This study tests an oral tablet called florensocatib (also known as CHF10196) to see if it can reduce lung infections in people with bronchiectasis. It is given alongside your usual care, and may help you have fewer flare-ups.
This study tests an investigational drug called VX-581 in healthy volunteers to see how safe it is and how the body handles it. It is an early-phase trial, so it helps determine the right dose for future studies.
This study tests a drug called dorzagliatin to see if it can help control blood sugar in adults with cystic fibrosis who have pancreatic insufficiency and abnormal glucose tolerance.
This trial tests how well cystic fibrosis (CF) medicine works for you using an “n-of-1” approach, meaning you try treatments in a structured, repeated way to see what helps you most. It may help your care team choose the best option for your specific CF genetics and health status.
This study tests whether a special nutrition supplement can improve health in adults with cystic fibrosis and pancreatic insufficiency who are already on a modulator therapy. The goal is to see if the supplement helps with digestion and overall well-being.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.